Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MANEA Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA552784
Description
Immunogen sequence: GVLALSWYPP DVNDENGEPT DNLVPTILDK AHKYNLKVTF HIEPYSNRDD QNMYKNVKYI IDKYGNHPAF YRYKTKTGNA LPMFYVYDSY ITKPEKWANL LTTSGSRSIR NSPYDGLFIA LLVEEKHKYD ILQSGFDGIY T Highest antigen sequence identity to the following orthologs: Mouse - 87%, Rat - 88%.
N-glycosylation of proteins is initiated in the endoplasmic reticulum (ER) by the transfer of the preassembled oligosaccharide glucose-3-mannose-9-N-acetylglucosamine-2 from dolichyl pyrophosphate to acceptor sites on the target protein by an oligosaccharyltransferase complex. This core oligosaccharide is sequentially processed by several ER glycosidases and by an endomannosidase (E.C. 3.2.1.130), such as MANEA, in the Golgi. MANEA catalyzes the release of mono-, di-, and triglucosylmannose oligosaccharides by cleaving the alpha-1,2-mannosidic bond that links them to high-mannose glycans (Hamilton et al., 2005).
Specifications
MANEA | |
Polyclonal | |
Unconjugated | |
MANEA | |
4932703L02Rik; alpha 1,2-endomannosidase; ENDO; Endo-alpha mannosidase; endomannosidase; glycoprotein endo-alpha-1,2-mannosidase; hEndo; Mandaselin; Manea; mannosidase endo-alpha; mannosidase, endo-alpha; mEndo | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
79694 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q5SRI9 | |
MANEA | |
Recombinant protein corresponding to Human MANEA. Recombinant protein control fragment (Product #RP-90480). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction